Conformational analysis of therapeutic proteins by hydroxyl radical protein footprinting
about
Analytical techniques and bioactivity assays to compare the structure and function of filgrastim (granulocyte-colony stimulating factor) therapeutics from different manufacturers.Characterizing monoclonal antibody structure by carbodiimide/GEE footprintingSupercharging by m-NBA Improves ETD-Based Quantification of Hydroxyl Radical Protein Footprinting.Investigating Therapeutic Protein Structure with Diethylpyrocarbonate Labeling and Mass Spectrometry.Protein Footprinting Comes of Age: Mass Spectrometry for Biophysical Structure Assessment.Structural characterization of semen coagulum-derived SEM1(86-107) amyloid fibrils that enhance HIV-1 infection.An improved fast photochemical oxidation of proteins (FPOP) platform for protein therapeutics.Structural analysis of a therapeutic monoclonal antibody dimer by hydroxyl radical footprinting.Complementary MS methods assist conformational characterization of antibodies with altered S-S bonding networks.Mass spectrometry for the biophysical characterization of therapeutic monoclonal antibodiesChemokine oligomerization in cell signaling and migration.High-resolution MS for structural characterization of protein therapeutics: advances and future directions.Characterizing monoclonal antibody structure by carboxyl group footprinting.Lysine conjugation properties in human IgGs studied by integrating high-resolution native mass spectrometry and bottom-up proteomics.MS in the analysis of biosimilars.Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator ProductCovalent labeling-mass spectrometry with non-specific reagents for studying protein structure and interactions
P2860
Q30355888-EC6B0AD2-EDE7-42D8-85CC-998A95376C93Q30369478-E5F1F8A3-CE13-4183-8819-03BE8B5807B8Q30374162-6B7BF438-E3F5-484C-8DA4-00AE95523835Q30379478-1BAF418F-60A5-4D36-8E38-94A3E90480EDQ30399662-986D2E64-B7A0-4FF1-BF97-F71C7EEE4C84Q33689504-8B700877-1AA0-433D-A96E-29E97BE53B40Q35528871-4CD6C05A-7199-4519-A61E-541EA28A844CQ36588729-B1472D3D-BFA8-4698-8064-66495354E7C7Q36836949-9AD75281-F658-4B14-AE0F-7666FBDFC09DQ37567087-E835040F-77C8-48D0-A10E-AC047C533DD5Q37608845-EE3D54E7-FF2D-45EF-918F-2ADFBF704520Q38110611-1F9CB485-8D67-4250-B4E8-AE25DB10AA07Q40987519-2285A481-2D10-4462-AB6D-C00DE2048C66Q41495558-9082B1DB-D6F5-4042-9840-5306BC45D761Q44031303-59A9F453-21E4-4D7F-9A63-1C1E772E8159Q57049370-F285878C-D464-47AD-89BC-3A5FFB25AB02Q57175988-0045EFF6-9D60-4D7F-9760-2E2E8FAB952A
P2860
Conformational analysis of therapeutic proteins by hydroxyl radical protein footprinting
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Conformational analysis of therapeutic proteins by hydroxyl radical protein footprinting
@ast
Conformational analysis of therapeutic proteins by hydroxyl radical protein footprinting
@en
type
label
Conformational analysis of therapeutic proteins by hydroxyl radical protein footprinting
@ast
Conformational analysis of therapeutic proteins by hydroxyl radical protein footprinting
@en
prefLabel
Conformational analysis of therapeutic proteins by hydroxyl radical protein footprinting
@ast
Conformational analysis of therapeutic proteins by hydroxyl radical protein footprinting
@en
P2860
P1433
P1476
Conformational analysis of therapeutic proteins by hydroxyl radical protein footprinting
@en
P2093
Caroline Watson
Joshua S Sharp
P2860
P2888
P304
P356
10.1208/S12248-012-9336-7
P407
P577
2012-03-02T00:00:00Z
P5875
P6179
1000849203